Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis
- 1 March 2011
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 25 (2) , 325-328
- https://doi.org/10.1111/j.1399-0012.2010.01283.x
Abstract
Patients who undergo hematopoietic stem cell transplantation (HSCT) frequently experience gastrointestinal toxicity as a result of their preparative regimen. The most frequent manifestation is oral mucositis (OM) and diarrhea. We studied the effects of oral care prior to HSCT on the severity of OM. Seventy patients suffering from hematologic malignancies who had undergone HSCT were divided into two groups (35 patients - Study Group [SG] and 35 - Control Group [CG]), and the severity of OM was evaluated by two calibrated dentists, using the WHO scale. The patients from the SG received oral care prior to HSCT and those from CG did not receive any dental care. The results showed no differences (p = 0.20) in the incidence or severity of OM among the groups. However, patients from the SG presented a shorter time elapsed (p < 0.001) when compared with the CG (median: 10 vs. 20 d). Our results show the importance of simple, inexpensive preventive intervention to control the time elapsed of OM, which reduces morbidity and, as a consequence, the cost of the treatment.Keywords
This publication has 14 references indexed in Scilit:
- The role of basic oral care and good clinical practice principles in the management of oral mucositisSupportive Care in Cancer, 2006
- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2004
- The pathobiology of mucositisNature Reviews Cancer, 2004
- Oral and intestinal mucositis — causes and possible treatmentsAlimentary Pharmacology & Therapeutics, 2003
- Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcomeClinical Oral Investigations, 2003
- Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and TreatmentCA: A Cancer Journal for Clinicians, 2001
- Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2001
- Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueBritish Journal of Haematology, 2000
- Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomised controlled trial comparing two protocols of dental careOral Oncology, 1994
- Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation development of an oral mucositis indexCancer, 1992